I had a chance today to address employees of Celgene, makers of pomalidomide, the investigational drug that has kept my myeloma stable for more than four years now. I’m grateful for the drug, and told them so. They seemed pleased, and I had a lot of fun.
Celgene recently announced that they have submitted pomalidomide to the FDA for approval, see previous post. I will be delighted when the drug is accessible to even more people.